Why so much excitement about CAR-T cells?
By Kristen Mueller, Ph.D., MRA Scientific Program Director | 18 July 2017 In News, Science, Treatment
July 12, 2017, marked a historic day for medicine and for the US Food and Drug Administration (FDA) when an expert advisory committee to the FDA unanimously endorsed the first ever genetically engineered, cell-based therapy for use in patients.
Melanoma Treatments: Breakthroughs for Multiple Cancers — for Real and Right Now
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 July 2017 In Science, Treatment
While 2014 and 2015 offered a whirlwind of good news related to new melanoma treatments from immune to targeted therapy, since then, it’s been a bit quieter in melanoma. Although there has been exceptional news in regard to other cancers. Why is that, and what are the latest breakthroughs?
Sunscreen Laws may Hinder Protecting Children from Exposure
With the launch of summer comes conventional discussion around ranking sunscreens, and chatter between the experts to parse what should be considered in choosing the most effective among them. It’s also a key conversation among parents heading into the season with an eye on protecting their children from sun exposure. Yet, something remaining a central concern among those parents is the public policy surrounding use of sunscreen in schools.
Melanoma Research Alliance and the American Cancer Society Forge Research Partnership to Maximize Immunotherapy Benefit to Patients
The Melanoma Research Alliance (MRA) and the American Cancer Society (ACS) are partnering to fund much-needed research aimed at decreasing rare, but serious, side effects associated with checkpoint inhibitors in hopes of increasing further cancer immunotherapy benefit to patients.
MAC: A Valued Partner in the Fight Against Melanoma
What do you do after the melanoma diagnosis has settled in and you’ve done all you can to ensure the best health outcome for yourself? Or even worse, what do you do after you’ve lost a spouse or a child to melanoma? For the members of the Melanoma Action Coalition, the answer is clear. You take that fear or sorrow, and you mobilize.
Non-invasive Detection Modalities and Metastatic Risk Stratification for Melanoma: Where Are We Now?
By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 10 July 2017 In Prevention, Science, Treatment
While dermatologists have advocated for patient education about irregular skin lesions in order to catch melanomas earlier, dermatologists ultimately play the largest role in the detection and excision of abnormal skin lesions via skin biopsy. However, visual recognition and assessment of pigmented skin lesions is limited to the eye of the dermatologist, and can be challenging for even the most experienced clinicians.
Melanoma Research Alliance Welcomes New Chief Development Officer
Following 22 years of fundraising and management experience in healthcare, higher education and NPOs, Joan Russo is joining the Melanoma Research Alliance (MRA) as Chief Development Officer.
Strides and Obstacles in Melanoma Research Spotlight on Martin McMahon, PhD
Like so many in the melanoma research field, Martin McMahon, PhD, Huntsman Cancer Institute’s senior director of pre-clinical translation and Professor at the University of Utah, entered the melanoma field by accident.
Invincible, Until You’re Not
Self described, lifetime sun worshiper and tanning bed devotee, 24-year old native Texan Ali Young was barely daunted the first time she was diagnosed with deadly skin cancer at the age of 18. Matter of fact, she recalls heading to the tanning bed the very day after her biopsy.
Melanoma Clinical Oncology Research: Interview with Dr. Joshua Arbesman
By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 6 June 2017 In Science, Treatment
As a third year medical student, MD Candidate Pooja Rambhia had the privilege of conducting an elective research year under Dr. Joshua Arbesman’s mentorship at University Hospitals Cleveland Medical Center. Arbesman has a unique role in translational basic science research within the realm of familial melanoma.
Accelerated Approval Advocacy Allies Anti-PD-1 ASCO Awareness Biopharma biopsy Board Members BRAF Cancer Capitol Hill Clinical Trials Collaborations Combination Therapies Corporate Partners Detection Diagnostics Drug Development Events Expanded Access Program FDA Francis Collins Funding Fundraising Genetics Health HHS immune checkpoint inhibitors Immunotherapies Immunotherapy Indoor Tanning ipilimumab Legislation Leveraged Finance Fights Melanoma LFFM Louise Perkins May Medical Research Melanoma Melanoma Awareness Melanoma Awareness Month Melanoma Prevention Melanoma Research Melanoma Survivors MRA MRA Researchers News NIH Nonprofits Partnering Partnering For Cures Partnerships PASS Coalition Patient Advocacy Patient Story Patient-Centric Care Patients Pediatric Melanoma Policy Prevention Redheads Research research collaboration research funding research grants Researchers Science Sequestration skin biopsy Skin Cancer Skin Cancer Prevention Skin Checks Social Media Sun Safety Sunburn Sunscreen Sunscreen Innovation Act Surgeon General Survivor Story Tanning Tanning Bans Tanning Bed Tanning Bed Ban Tanning Beds targeted therapy Teens Treatments UPF Clothing Wendy Selig Young People